Treatment Outcomes for Patients Undergoing Hemodialysis with Chronic Hepatitis C on the Sofosbuvir and Daclatasvir Regimen

Background Hepatitis C (HCV) infection is the most commonly acquired infection for patients on hemodialysis and is associated with significant morbidity and disease progression. Direct-acting antivirals (DAAs) have revolutionized the management of HCV. However, limited data exist regarding their eff...

詳細記述

保存先:
書誌詳細
出版年:Cureus
主要な著者: Butt, Nazish, Abbasi, Amanullah, Ali Khan, M, Ali, Muhammad, Mahesar, Ghulam B, Haleem, Farhan, Manan, Abdul
フォーマット: Artigo
言語:Inglês
出版事項: Cureus 2019
主題:
Gastroenterology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6823026/
https://ncbi.nlm.nih.gov/pubmed/31720170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5702
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料